DP

Diadema Partners Portfolio holdings

AUM $144M
1-Year Est. Return 22.15%
This Quarter Est. Return
1 Year Est. Return
+22.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$161M
AUM Growth
+$35.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
94
New
Increased
Reduced
Closed

Top Buys

1
+$16M
2
+$14.5M
3
+$7.7M
4
TGTX icon
TG Therapeutics
TGTX
+$5.89M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.45M

Top Sells

1
+$12.7M
2
+$3.54M
3
+$3.5M
4
ARGX icon
argenx
ARGX
+$3.48M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$2.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVPH icon
26
Reviva Pharmaceuticals
RVPH
$57.3M
$1.04M 0.32%
2,735,457
+2,084,734
MNMD icon
27
MindMed
MNMD
$1.1B
$1.03M 0.31%
+158,536
TRVI icon
28
Trevi Therapeutics
TRVI
$1.38B
$1.02M 0.31%
185,830
+5,830
TERN icon
29
Terns Pharmaceuticals
TERN
$2.03B
$969K 0.3%
259,852
+203,754
ETNB
30
DELISTED
89bio
ETNB
$966K 0.29%
98,382
-133,054
CLYM
31
Climb Bio
CLYM
$130M
$871K 0.27%
702,135
+32,332
SCPH
32
DELISTED
scPharmaceuticals
SCPH
$829K 0.25%
+217,623
VTGN icon
33
VistaGen Therapeutics
VTGN
$117M
$808K 0.25%
403,922
-162,053
ARVN icon
34
Arvinas
ARVN
$679M
$710K 0.22%
+96,455
APGE icon
35
Apogee Therapeutics
APGE
$4.47B
$459K 0.14%
10,572
-29,428
PHAT icon
36
Phathom Pharmaceuticals
PHAT
$1.04B
$386K 0.12%
+40,294
NUVL icon
37
Nuvalent
NUVL
$7.02B
$382K 0.12%
+5,000
ALEC icon
38
Alector
ALEC
$135M
$372K 0.11%
266,023
-190,523
PRQR icon
39
ProQR Therapeutics
PRQR
$229M
$322K 0.1%
157,694
-50,000
REPL icon
40
Replimune Group
REPL
$705M
$302K 0.09%
32,483
-42,047
ELDN icon
41
Eledon Pharmaceuticals
ELDN
$132M
$175K 0.05%
64,613
RLAY icon
42
Relay Therapeutics
RLAY
$1.09B
$151K 0.05%
43,616
-382,730
ELEV
43
DELISTED
Elevation Oncology
ELEV
$133K 0.04%
+362,935
PRTC
44
PureTech Health
PRTC
$391M
$126K 0.04%
+7,324
SMMT icon
45
Summit Therapeutics
SMMT
$13.4B
$19.8K 0.01%
+932
ZLAB icon
46
Zai Lab
ZLAB
$2.41B
$13.2K ﹤0.01%
+3,785
BBIO icon
47
BridgeBio Pharma
BBIO
$12.8B
– –
0
BHVN icon
48
Biohaven
BHVN
$1.1B
– –
0
FOLD icon
49
Amicus Therapeutics
FOLD
$2.92B
– –
0
SPRY icon
50
ARS Pharmaceuticals
SPRY
$812M
– –
0
1
2
3 4